Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Practical Workflow Guide

What This Product Solves

The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the frequent need for reliable, fluorescence-based detection of goat-derived primary antibodies in immunodetection workflows. By combining affinity purification against both heavy and light chains with Cy3 conjugation, this reagent enables robust signal amplification and low-background detection in applications such as immunocytochemistry (ICC/IF), immunohistochemistry (IHC) on frozen or paraffin sections, flow cytometry, and ELISA. Its specificity for goat IgG makes it suitable for protocols where clarity and reproducibility are critical, and its fluorescent tag supports sensitive, multiplex-compatible detection without enzymatic development steps. For further technical background and stepwise use recommendations, see the in-depth technical use guide at this internal article, which details detection strategies and boundaries for goat primaries. Additional workflow-focused advice is provided in this technical workflow guide, emphasizing best practices for signal amplification and specificity in advanced immunodetection.

Protocol Parameters

• Assay: ICC/IF, IHC-Fr, IHC-P
  Recommended dilution: 1:200–1:1000 (user-optimized)
  Applicability: Fluorescent detection of goat primary antibodies on tissue/cell samples.
  Rationale: Allows titration based on sample abundance and background; avoids over-saturation.
  Source type: workflow recommendation
• Assay: Flow Cytometry
  Recommended dilution: 1:500–1:2000 (user-optimized)
  Applicability: Detection of cell-surface or intracellular antigens with goat primaries.
  Rationale: Ensures sufficient labeling intensity while minimizing background; titrate for instrument sensitivity.
  Source type: workflow recommendation
• Assay: ELISA
  Suggested working concentration: 0.5–2 µg/mL
  Applicability: Detection of goat primary antibodies in enzyme-linked assays.
  Rationale: Maintains linear signal response and low background; concentration may be optimized per plate setup.
  Source type: workflow recommendation
• Specification: Stock concentration 1 mg/mL; buffer with 23% glycerol, 1% BSA, 0.02% sodium azide
  Applicability: All supported immunodetection workflows.
  Rationale: Provides stability and minimizes freeze-thaw degradation; BSA reduces non-specific binding.
  Source type: product dossier
• Storage: Aliquot and store at -20°C for up to 12 months, protect from light
  Applicability: All workflows.
  Rationale: Preserves Cy3 signal and antibody integrity; short-term at 4°C (<2 weeks) permissible.
  Source type: product dossier

Workflow Setup and QC Checklist

• Aliquot upon receipt: Upon delivery, aliquot the antibody to minimize freeze-thaw cycles, which can degrade both the antibody and Cy3 fluorescence. Store aliquots at -20°C in the dark.
• Light protection: Cy3 is sensitive to photobleaching; always handle the antibody and stained samples under low-light conditions. Use amber tubes or wrap vials in foil if needed.
• Blocking steps: Employ blocking buffers (e.g., 1% BSA, serum) appropriate to sample and primary antibody species to minimize non-specific binding. Insufficient blocking is a common source of background.
• Primary antibody validation: Confirm that the primary antibody is of goat origin and well-characterized for the intended target and sample type; this secondary will not recognize other species.
• Instrument settings (for flow cytometry/fluorescence): Set excitation at 552 nm and collect emission at 565 nm to maximize Cy3 signal; adjust compensation as required for multiplexed panels.
• Negative and positive controls: Include secondary-only and known positive controls in each run to monitor for background and validate signal specificity.
• Wash stringency: Use sufficient washing between steps (e.g., 3 × 5 min washes in PBS) to remove excess antibody and reduce background, especially in tissue sections.

Common Failure Modes and Fixes

• High background fluorescence: May result from insufficient blocking, over-concentrated antibody, or inadequate washing. Solution: Increase blocking reagent concentration, titrate antibody to lower dilution, and lengthen wash steps.
• Weak or absent signal: Potential causes include photobleaching, expired antibody, incorrect excitation/emission settings, or using a non-goat primary. Solution: Protect from light, verify antibody storage, confirm instrument filters, and ensure the primary is goat IgG.
• Non-specific staining: Can occur if the secondary cross-reacts due to inadequate blocking or species overlap in complex samples. Solution: Optimize blocking, validate tissue specificity, and consider pre-adsorption steps if necessary.
• Batch-to-batch variability: Minimized by affinity purification as per product dossier but monitor new lots for consistent performance using controls.

Scope and Limitations

This Cy3-conjugated secondary antibody is validated for ICC/IF, IHC (frozen and paraffin), flow cytometry, and ELISA detection formats using goat IgG primaries. It should not be used with non-goat primary antibodies or in applications outside immunodetection (such as direct protein quantification, western blotting unless specifically validated, or non-fluorescence-based methods). The antibody's specificity relies on immunoaffinity purification, but off-target binding can occur if blocking and washing are insufficient. Always consult the Cy3 Rabbit Anti-Goat IgG (H+L) Antibody product information for details on buffer compatibility, storage, and use boundaries. For optimal signal amplification in immunodetection, follow established protocols and avoid speculative cross-domain applications. APExBIO does not provide evidence for non-immunodetection use.

Conclusion

The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific detection of goat-derived primaries in fluorescence-based immunodetection workflows. Its combination of affinity purification and Cy3 labeling supports robust signal amplification across ICC/IF, IHC, flow cytometry, and ELISA. For reproducible results, adhere closely to storage, handling, and protocol recommendations, and avoid use with incompatible primary antibodies or outside the defined scope. For additional technical advice and updated protocol strategies, refer to APExBIO and linked internal resources.